TG Therapeutics | TGTX - Cash And Equivalent

Stock Price
28.47
Daily Change
0.71 2.56%
Monthly
-6.16%
Yearly
-13.96%
Q1 Forecast
28.52

TG Therapeutics reported $178.32M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AbbVie USD 5.63B 838M Sep/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Amgen USD 9.13B 316M Dec/2025
Ardelyx USD 42.72M 47.32M Sep/2025
Arrowhead Research USD 201.64M 112.94M Dec/2025
Bayer EUR 5.9B 1.34B Sep/2025
Biogen USD 3.01B 854.3M Dec/2025
Corcept Therapeutics USD 125.14M 22.39M Sep/2025
Dynavax Technologies USD 160.25M 61.15M Sep/2025
Gilead Sciences USD 5.14B 2.78B Jun/2025
J&J USD 18.23B 10.35B Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
PTC Therapeutics USD 672.62M 344.77M Sep/2025
Regeneron Pharmaceuticals USD 18.87B 16.36B Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
TG Therapeutics USD 178.32M 100.54M Sep/2025
Vertex Pharmaceuticals USD 6.29B 95.8M Sep/2025